Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
08:47
The Bucharest Court of Appeal decides today whether Călin Georgescu remains in pretrial detention or is placed under house arrest
08:31
Republicans in the U.S. Senate rejected the resolution that limited Donald Trump’s military involvement in the war in Iran
08:30
The reason Donald Trump did not meet with Kim Jong-Un at the APEC summit: “There were too many meetings, it wouldn’t have worked” / The American president still intends to meet with the North Korean leader
08:15
Minister of Defense, on detecting drones that enter Romania’s airspace without authorization: “It is important to exchange information, to work together, and to have equipment that enables us to see better”
08:00
Ukraine: Two bridges in Kyiv were damaged following attacks with Russian ballistic missiles
See more news